{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:57:53Z","timestamp":1769216273706,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.brachy.2012.10.002","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T20:37:11Z","timestamp":1360010231000},"page":"217-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prostate brachytherapy in men with gland volume of 100 cc or greater: Technique, cancer control, and morbidity"],"prefix":"10.1016","volume":"12","author":[{"given":"Nelson N.","family":"Stone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard G.","family":"Stock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2012.10.002_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijrobp.2008.04.038","article-title":"Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy","volume":"73","author":"Stone","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.10.002_bib2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijrobp.2010.05.042","article-title":"Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience","volume":"81","author":"Sylvester","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.10.002_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0360-3016(99)00176-5","article-title":"Urinary morbidity following ultrasound-guided transperineal prostate seed implantation","volume":"45","author":"Gelblum","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.10.002_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.urology.2006.10.001","article-title":"Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years","volume":"69","author":"Stone","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2012.10.002_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1538-4721(03)00012-6","article-title":"Prospective long-term analysis of urinary symptoms and quality of life in men with large or small prostates treated with prostate brachytherapy","volume":"2","author":"Stone","year":"2003","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2012.10.002_bib6","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0360-3016(99)00516-7","article-title":"Prostate brachytherapy in patients with prostate volumes > 50 cm3: Dosimetric analysis of implant quality","volume":"46","author":"Stone","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.10.002_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijrobp.2005.07.981","article-title":"Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsies","volume":"64","author":"Stock","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.10.002_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0360-3016(95)00521-Y","article-title":"A modified technique allowing interactive ultrasound guided three-dimensional transperineal prostate implantation","volume":"32","author":"Stock","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.10.002_bib9","first-page":"95","article-title":"Intraoperative dosimetric representation of the real-time ultrasound guided prostate implant","volume":"6","author":"Stock","year":"2000","journal-title":"Tech Urol"},{"key":"10.1016\/j.brachy.2012.10.002_bib10","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0360-3016(00)00707-0","article-title":"Post-implant dosimetry for I-125 prostate implants: definitions and factors affecting outcome","volume":"48","author":"Stock","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.10.002_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.juro.2010.09.099","article-title":"Influence of pre-treatment and treatment factors on intermediate to long-term outcomes following prostate brachytherapy","volume":"185","author":"Stone","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2012.10.002_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1538-4721(03)00005-9","article-title":"Comparison of intraoperative dosimetric implant representation to post-implant dosimetry in patients receiving prostate brachytherapy","volume":"2","author":"Stone","year":"2003","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2012.10.002_bib13","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.juro.2006.10.018","article-title":"The effect of brachytherapy, external beam irradiation and hormonal therapy on prostate volume","volume":"177","author":"Stone","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2012.10.002_bib14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0302-2838(03)00134-9","article-title":"The impact of prostate volume following neoadjuvant androgen deprivation on quality of life and voiding symptoms in patients undergoing permanent prostate brachytherapy","volume":"43","author":"Krupski","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2012.10.002_bib15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0360-3016(02)04600-X","article-title":"Long-term urinary quality of life after permanent prostate brachytherapy","volume":"56","author":"Merrick","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.10.002_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11934-011-0183-3","article-title":"Update on prostate brachytherapy: Long-term outcomes and treatment-related morbidity","volume":"12","author":"Kao","year":"2011","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.brachy.2012.10.002_bib17","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.juro.2009.09.084","article-title":"Does neoadjuvant hormonal therapy improve urinary function when given to men with very large prostates undergoing prostate brachytherapy?","volume":"183","author":"Stone","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2012.10.002_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0360-3016(01)01442-0","article-title":"Defining the risk of developing grade 2 proctitis following I-125 prostate brachytherapy using a rectal dose volume histogram analysis","volume":"50","author":"Snyder","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.10.002_bib19","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.ijrobp.2007.02.052","article-title":"A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy","volume":"68","author":"Cesaretti","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472113000172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472113000172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:06:22Z","timestamp":1761530782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472113000172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1538472113000172"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2012.10.002","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate brachytherapy in men with gland volume of 100cc or greater: Technique, cancer control, and morbidity","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2012.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}